Is the negative prognostic value of high oestrogen receptor (ER) levels in postmenopausal breast cancer patients due to a modified ER gene product?

This publication has 24 references indexed in Scilit:

• Estrogen receptors (ER) in human breast cancer. The significance of a new prognostic factor based on both ER protein and ER mRNA contents
  Cancer, 1994
• Short recurrence-free survival associated with high oestrogen receptor levels in the natural history of postmenopausal, primary breast cancer
  European Journal Of Cancer, 1993
• Human breast cancer: identification of populations with a high risk of early relapse in relation to both oestrogen receptor status and c-erbB-2 overexpression
  British Journal of Cancer, 1990
• Histochemical estrogen binding An independent predictor of recurrence and survival in stage II breast cancer
  Cancer, 1986
• Prognostic significance of estrogen receptor status in breast cancer in relation to tumor stage, axillary node metastasis, and histopathologic grading
  Cancer, 1984
• Estrogen receptors and long-term prognosis in breast cancer
  Cancer, 1984
• STEROID-HORMONE RECEPTORS AND SURVIVAL AFTER FIRST RELAPSE IN BREAST CANCER
  The Lancet, 1984
• Relation of estrogen and/or progesterone receptor content of breast cancer to patient outcome following adjuvant chemotherapy
  Breast Cancer Research and Treatment, 1983
• Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer. An NSABP update
  Cancer, 1983
• Prognostic value of estrogen receptors in primary breast cancer
  Cancer, 1979